Pacira BioSciences (PCRX) Amortization - Intangibles (2019 - 2026)

Pacira BioSciences' Amortization - Intangibles history runs 8 years deep, the most recent figure standing at $14.3 million for Q1 2026.

• In Q1 2026, Amortization - Intangibles changed 0.15% year-over-year to $14.3 million; the TTM figure through Mar 2026 stood at $57.3 million (changed 0.04% YoY), while the FY2025 annual figure was $57.3 million, changed 0.02% from the prior year.
• Amortization - Intangibles was $14.3 million for Q1 2026 at Pacira BioSciences, roughly flat from $14.3 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $14.3 million in Q1 2022 to a low of $14.3 million in Q4 2022.
• Historically, Amortization - Intangibles has averaged $14.3 million across 5 years, with a median of $14.3 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Amortization - Intangibles soared 628.11% in 2022, then retreated 0.15% in 2023.
• A 5-year view of Amortization - Intangibles shows it stood at $14.3 million in 2022, then gained by 0.24% to $14.3 million in 2023, then changed by 0.0% to $14.3 million in 2024, then declined by 0.15% to $14.3 million in 2025, then gained by 0.15% to $14.3 million in 2026.
• The last three Amortization - Intangibles figures came in at $14.3 million (Q1 2026), $14.3 million (Q4 2025), and $14.3 million (Q3 2025), per Business Quant data.